OncoTherapy Science
4564.TTSE GROWTHPharmaceutical
Major holders (5%+) · 1
| Holder | Stake |
|---|---|
| Yusuke Nakamura | 6.05% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 1
| Long Corridor Asset Management Limited | 4.63% |
Ownership history · 51
| Holder | Ratio | Change |
|---|---|---|
| Yusuke Nakamura2026-09-11 | 6.05% | -0.44pp |
| Yusuke Nakamura2026-09-11 | 6.49% | no change |
| Yusuke Nakamura2026-09-11 | 6.49% | new |
| Long Corridor Asset Management Limited2026-06-15 | 4.63% | -1.18pp |
| Long Corridor Asset Management Limited2026-06-11 | 5.81% | no change |
| Long Corridor Asset Management Limited2026-06-10 | 5.81% | -1.23pp |
| Long Corridor Asset Management Limited2026-04-21 | 7.04% | -1.13pp |
| Long Corridor Asset Management Limited2026-04-20 | 8.17% | no change |
| Long Corridor Asset Management Limited2026-04-20 | 8.17% | -1.42pp |
| Long Corridor Asset Management Limited2026-04-13 | 9.59% | +0.23pp |
| Long Corridor Asset Management Limited2026-03-24 | 9.36% | -1.25pp |
| Long Corridor Asset Management Limited2026-02-06 | 10.61% | -0.81pp |
| Long Corridor Asset Management Limited2026-01-30 | 11.42% | -1.14pp |
| Long Corridor Asset Management Limited2026-01-14 | 12.56% | -1.04pp |
| Long Corridor Asset Management Limited2025-12-26 | 13.60% | -0.10pp |
| Long Corridor Asset Management Limited2025-12-24 | 13.70% | -1.56pp |
| Long Corridor Asset Management Limited2025-12-24 | 15.26% | -1.18pp |
| Long Corridor Asset Management Limited2025-12-19 | 16.44% | -1.19pp |
| Long Corridor Asset Management Limited2025-12-19 | 17.63% | no change |
| Long Corridor Asset Management Limited2025-12-15 | 17.63% | -1.18pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.